Proteomic approaches in cancer risk and response assessment
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (2) , 59-64
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarraysProteomics, 2003
- Signal pathway profiling of prostate cancer using reverse phase protein arraysProteomics, 2003
- Molecular Networks: The Top-Down ViewScience, 2003
- The Vision for a New Diagnostic ParadigmClinical Chemistry, 2003
- Mass Spectrometry-based Diagnostics: The Upcoming Revolution in Disease DetectionClinical Chemistry, 2003
- Use of Proteomic Patterns in Serum to Identify Ovarian CancerObstetrical & Gynecological Survey, 2002
- Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growthAnnals of Oncology, 2002
- Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer PredictionGynecologic Oncology, 2001
- Cell Surface Receptor-Targeted Therapy of Acute Myeloid Leukemia: A ReviewCancer Biotherapy and Radiopharmaceuticals, 2000
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983